Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Federal Trade Commission
Teva
Queensland Health
Dow
McKinsey
Chinese Patent Office
Harvard Business School
Julphar

Generated: April 20, 2018

DrugPatentWatch Database Preview

TRANDOLAPRIL Drug Profile

« Back to Dashboard

Which patents cover Trandolapril, and what generic alternatives are available?

Trandolapril is a drug marketed by Aurobindo Pharma, Cipla, Dr Reddys Labs Ltd, Epic Pharma, Epic Pharma Llc, Invagen Pharms, Lupin, Mylan, Teva Pharms, Watson Labs, and Glenmark Generics. and is included in eleven NDAs.

The generic ingredient in TRANDOLAPRIL is trandolapril; verapamil hydrochloride. There are ten drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the trandolapril; verapamil hydrochloride profile page.
Drug patent expirations by year for TRANDOLAPRIL
Pharmacology for TRANDOLAPRIL
Synonyms for TRANDOLAPRIL
(2S,3aR,7aS)-1-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl)octahydro-1H-indole-2-carboxylic acid
(2S,3aR,7aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester
(2S,3aR,7aS)-1-(N-((1S)-1-((Ethyloxy)carbonyl)-3-phenylpropyl)-L-alanyl)octahydro-1H-indole-2-carboxylic Acid
(2s,3ar,7as)-1-[(2s)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-1h-indole-2-carboxylic acid
(2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxidanylidene-4-phenyl-butan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid
(2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-1-oxopropyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid
(2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid
(2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylicacid
(2S,3aR,7aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydro-1H-indole-2-carboxylic acid
1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-1H-indol-2-carboxylic acid
1H-Indole-2-carboxylic acid, 1-((2S)-2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-, (2S,3aR,7aS)-
1H-Indole-2-carboxylic acid, octahydro-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)-, (2S-(1(R*(R*)),2-alpha,3a-alpha,7a-beta))-
1T0N3G9CRC
679T376
87679-37-6
A842336
AC1NUNSR
AK163083
AKOS015843316
AKOS015896050
AM035968
API0004465
AX8035229
BDBM50369775
BG0519
BIDD:GT0804
C24H34N2O5
CAS-87679-37-6
CCG-222228
CCRIS 6594
CHEBI:9649
CHEMBL1519
CI-907
CS-2809
CTK8E8021
D00383
D0M5OC
DB00519
DR002663
DSSTox_CID_3692
DSSTox_GSID_23692
DSSTox_RID_77151
DTXSID2023692
FT-0082544
Gopten
GTPL6453
HMS3262J10
HY-B0592
I06-1849
Indolapril
KB-81195
KS-1467
LP00924
LS-82763
Mavik
Mavik (TN)
MFCD00865776
MolPort-006-167-568
NCGC00095153-01
NCGC00182079-02
NCGC00182079-03
NCGC00261609-01
Odric
Odrik
Preran
RU 44570
RU-44570
RU44570
SC-17973
SCHEMBL16610
SR-02000000917
SR-02000000917-2
ST24050183
TC-070968
Tox21_111453
Tox21_113152
Tox21_500924
Trandolapril (JAN/INN)
Trandolapril [INN:BAN]
Trandolapril [USP:INN:BAN]
Trandolapril, >=98% (HPLC), white powder
Trandolapril, European Pharmacopoeia (EP) Reference Standard
Trandolapril, United States Pharmacopeia (USP) Reference Standard
Trandolaprilum
Trandolaprilum [Latin]
Udrik
UNII-1T0N3G9CRC
VXFJYXUZANRPDJ-WTNASJBWSA-N
ZINC1853205

US Patents and Regulatory Information for TRANDOLAPRIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Generics TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE trandolapril; verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 079135-001 May 26, 2010 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs TRANDOLAPRIL trandolapril TABLET;ORAL 077805-001 Jun 12, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glenmark Generics TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE trandolapril; verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 079135-002 May 26, 2010 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs TRANDOLAPRIL trandolapril TABLET;ORAL 077805-002 Jun 12, 2007 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
McKinsey
Chinese Patent Office
Dow
US Army
QuintilesIMS
Harvard Business School
Queensland Health
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.